Interferon-Free Combination Therapy Is Effective for Hepatitis C Patients
Interferon-free regimens effective for hepatitis C virus genotype 1
By: MARY ANN MOON, Family Practice News Digital Network
An interferon-free regimen of faldaprevir, deleobuvir, and ribavirin proved to be effective in a phase II clinical trial involving 362 patients with previously untreated chronic hepatitis C virus genotype 1 infection, according to a report published in the New England Journal of Medicine.
The new combination therapy achieved sustained virologic response rates of 52%-69% 12 weeks after treatment was completed, reported Dr. Stefan Zeuzem of Johann Wolfgang Goethe University Medical Center, Frankfurt am Main (Germany), and his associates (N. Engl. J. Med. 2013;369:630-9).
Continue reading this entire article: